富血小板血浆治疗膝关节炎的研究进展

doi:10.3760/cma.j.issn.1007-1245.2024.24.009

国际医药卫生导报 ›› 2024, Vol. 30 ›› Issue (24): 4106-4109.DOI: 10.3760/cma.j.issn.1007-1245.2024.24.009

富血小板血浆治疗膝关节炎的研究进展

孙力石辉

滨州医学院附属医院骨关节与运动医学科，滨州　256600

收稿日期:2024-05-24 出版日期:2024-12-15 发布日期:2024-12-21
通讯作者: 石辉，Email：13475095025@163.com
基金资助:
山东省省级临床重点专科学科建设项目（SLCZDZK-0302）

Research progress on the treatment of knee osteoarthritis with platelet rich plasma

Sun Li, Shi Hui

Department of Orthopedics and Sports Medicine, Binzhou Medical University Hospital, Binzhou 256600, China

Received:2024-05-24 Online:2024-12-15 Published:2024-12-21
Contact: Shi Hui, Email: 13475095025@163.com
Supported by:
Shandong Provincial Clinical Key Specialized Discipline Construction Project (SLCZDZK-0302)

摘要/Abstract

摘要：

膝关节炎是临床常见慢性退行性疾病，尚无明确可阻止或逆转膝关节炎的治疗方法。富血小板血浆（PRP）是富含血小板的血浆制品，可缓解炎症反应，修复软骨损伤。PRP现已成为具有膝关节炎治疗前景的工具，本文对PRP临床应用与试验进行概述，为临床提供参考。

关键词:

Platelet rich plasma, Knee , osteoarthritis, Research progress, Application prospect

Abstract:

Osteoarthritis is a common chronic degenerative disease in orthopedic clinical practice, and there is currently no clear treatment method to prevent or reverse knee osteoarthritis. Platelet rich plasma (PRP) is a plasma product rich in platelets, which has significant advantages in alleviating inflammation and repairing cartilage damage. In recent studies, PRP has become a new tool with promising therapeutic prospects for knee osteoarthritis. This article provides an overview of the clinical applications and trials of PRP conducted by recent scholars, providing reference for clinical practice.

Key words:

Platelet rich plasma, Knee , osteoarthritis, Research progress, Application prospect

孙力石辉.

富血小板血浆治疗膝关节炎的研究进展 [J]. 国际医药卫生导报, 2024, 30(24): 4106-4109.

Sun Li, Shi Hui.

Research progress on the treatment of knee osteoarthritis with platelet rich plasma [J]. International Medicine and Health Guidance News, 2024, 30(24): 4106-4109.

参考文献

[1] Berenbaum F, Walker C. Osteoarthritis and inflammation: a serious disease with overlapping phenotypic patterns[J]. Postgrad Med, 2020, 132(4):377-384. DOI: 10.1080/00325481.2020.1730669.
[2] Hawker GA, King LK. The burden of osteoarthritis in older adults[J]. Clin Geriatr Med, 2022, 38(2):181-192. DOI: 10.1016/j.cger.2021.11.005.
[3] Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach[J]. PM R, 2011, 3(3):226-250. DOI: 10.1016/j.pmrj.2010.11.007.
[4] 赵子悦,黄韦华,查占山.富血小板血浆与间充质干细胞的联合应用在再生医学中的前景[J].临床输血与检验,2024,26(3):420-426.DOI:10.3969/j.issn.1671-2587.2024. 03.020.
[5] White C, Brahs A, Dorton D, et al. Platelet-rich plasma: a comprehensive review of emerging applications in medical and aesthetic dermatology[J]. J Clin Aesthet Dermatol, 2021, 14(11):44-57.
[6] 中国医疗保健国际交流促进会骨科分会.富血小板血浆在骨关节外科临床应用专家共识(2018年版)[J/CD].中华关节外科杂志(电子版),2018,12(5):596-600.DOI:10.3877/cma.j.issn.1674-134X.2018.05.001.
[7] Singh H, Knapik DM, Polce EM, et al. Relative efficacy of intra-articular injections in the treatment of knee osteoarthritis: a systematic review and network meta-analysis[J]. Am J Sports Med, 2022, 50(11):3140-3148. DOI: 10.1177/03635465211029659.
[8] Barman A, Mishra A, Maiti R, et al. Can platelet-rich plasma injections provide better pain relief and functional outcomes in persons with common shoulder diseases: a meta-analysis of randomized controlled trials[J]. Clin Shoulder Elb, 2022, 25(1):73-89. DOI: 10.5397/cise.2021.00353.
[9] Scott A, LaPrade RF, Harmon KG, et al. Platelet-rich plasma for patellar tendinopathy: a randomized controlled trial of leukocyte-rich PRP or leukocyte-poor PRP versus saline[J]. Am J Sports Med, 2019, 47(7):1654-1661. DOI: 10.1177/0363546519837954.
[10] 谢爱霞,李强强,何炎鸿,等.B超引导下注射富血小板血浆联合神经阻滞治疗肩周炎的研究进展[J].国际医药卫生导报,2023,29(22):3157-3161.DOI:10.3760/cma.j.issn.1007- 1245.2023.22.002.
[11] Samadi P, Sheykhhasan M, Khoshinani HM. The use of platelet-rich plasma in aesthetic and regenerative medicine: a comprehensive review[J]. Aesthetic Plast Surg, 2019, 43(3):803-814. DOI: 10.1007/s00266-018- 1293-9.
[12] Tramś E, Malesa K, Pomianowski S, et al. Role of platelets in osteoarthritis-updated systematic review and meta-analysis on the role of platelet-rich plasma in osteoarthritis[J]. Cells, 2022, 11(7):1080. DOI: 10.3390/cells11071080.
[13] Verma R, Negi G, Kandwal A, et al. Effect of autologous PRP on wound healing in dental regenerative surgeries and its correlation with PDGF levels[J]. Asian J Transfus Sci, 2019, 13(1):47-53. DOI: 10.4103/ajts.AJTS_25_17.
[14] 王丽娜,彭欣,董珉光,等.高选择性神经射频消融联合富血小板血浆治疗中重度膝骨关节炎的疗效分析[J].中国疼痛医学杂志,2024,30(5):384-389.DOI:10.3969/j.issn.1006- 9852.2024.05.010.
[15] Ornetti P, Nourissat G, Berenbaum F, et al. Does platelet-rich plasma have a role in the treatment of osteoarthritis?[J]. Joint Bone Spine, 2016, 83(1):31-36. DOI: 10.1016/j.jbspin.2015.05.002.
[16] Küçükakkaş O, Aydin T, Yurdakul OV. Evaluation of the effect of intra-articular platelet-rich plasma and hyaluronic acid injections on femoral cartilage thickness in chronic knee osteoarthritis[J]. Acta Orthop Belg, 2022, 88(4):811-819. DOI: 10.52628/88.4.10243.
[17] Belk JW, Kraeutler MJ, Houck DA, et al. Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials[J]. Am J Sports Med, 2021, 49(1):249-260. DOI: 10.1177/0363546520909397.
[18] Feller J. Platelet-rich plasma injections were not better than hyaluronic acid injections for knee joint degeneration[J]. J Bone Joint Surg Am, 2016, 98(4):315. DOI: 10.2106/JBJS.15.01441.
[19] 中国输血协会临床输血管理学专业委员会.自体富血小板血浆制备技术专家共识[J].中国输血杂志,2021,34(7):677-683.DOI:10.13303/j.cjbt.issn.1004- 549x.2021.07.001.
[20] Everts P, Onishi K, Jayaram P, et al. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020[J]. Int J Mol Sci, 2020, 21(20):7794. DOI: 10.3390/ijms21207794.
[21] Tjandra KC, Novriansyah R, Sudiasa INS, et al. Modified Mesenchymal stem cell, platelet-rich plasma, and hyaluronic acid intervention in early stage osteoarthritis: a systematic review, meta-analysis, and meta-regression of arthroscopic-guided intra-articular approaches[J]. PLoS One, 2024, 19(3):e0295876. DOI: 10.1371/journal.pone.0295876.
[22] Raeissadat SA, Rahimi M, Rayegani SM, et al. Cost-utility analysis and net monetary benefit of platelet rich plasma (PRP), intra-articular injections in compared to plasma rich in growth factors (PRGF), hyaluronic acid (HA) and ozone in knee osteoarthritis in Iran[J]. BMC Musculoskelet Disord, 2023, 24(1):22. DOI: 10.1186/s12891-022-06114-x.
[23] Raeissadat SA, Ghazi Hosseini P, Bahrami MH, et al. The comparison effects of intra-articular injection of platelet rich plasma (PRP), plasma rich in growth factor (PRGF), hyaluronic acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial[J]. BMC Musculoskelet Disord, 2021, 22(1):134. DOI: 10.1186/s12891-021- 04017-x.
[24] Tang JZ, Nie MJ, Zhao JZ, et al. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis[J]. J Orthop Surg Res, 2020, 15(1):403. DOI: 10.1186/s13018-020-01919-9.
[25] Carling MS, Jeppsson A, Eriksson BI, et al. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study[J]. J Orthop Surg Res, 2015, 10:48. DOI: 10.1186/s13018-015-0188-6.
[26] 袁明武,罗瀚文.全膝关节置换联合PRP在膝骨关节炎治疗中的应用研究[J].世界最新医学信息文摘,2019,19(45):72,77.DOI:10.19613/j.cnki.1671-3141.2019.45.039.
[27] Collins T, Alexander D, Barkatali B. Platelet-rich plasma: a narrative review[J]. EFORT Open Rev, 2021, 6(4):225-235. DOI: 10.1302/2058-5241.6.200017.
[28] Munde K, Banerjee S, Gahlot N, et al. Effect of platelet-rich plasma on healing of autologous graft after anterior cruciate ligament reconstruction: a randomized control trial[J]. Regen Med, 2023, 18(8):601-610. DOI: 10.2217/rme-2023-0108.
[29] Tschopp M, Pfirrmann CWA, Brunner F, et al. Morphological and quantitative parametric MRI follow-up of cartilage changes before and after intra-articular injection therapy in patients with mild to moderate knee osteoarthritis: a randomized, placebo-controlled trial[J]. Invest Radiol, 2024, 59(9):646-655. DOI: 10.1097/RLI.0000000000001067.
[30] Morishita M, Ishida K, Matsumoto T, et al. Intraoperative platelet-rich plasma does not improve outcomes of total knee arthroplasty[J]. J Arthroplasty, 2014, 29(12):2337-2341. DOI: 10.1016/j.arth.2014.04.007.
[31] Ye Z, Chen H, Qiao Y, et al. Intra-articular platelet-rich plasma injection after anterior cruciate ligament reconstruction: a randomized clinical trial[J]. JAMA Netw Open, 2024, 7(5):e2410134. DOI: 10.1001/jamanetworkopen.2024.10134.
[32] Barman A, Bandyopadhyay D, Mohakud S, et al. Comparison of clinical outcome, cartilage turnover, and inflammatory activity following either intra-articular or a combination of intra-articular with intra-osseous platelet-rich plasma injections in osteoarthritis knee: a randomized, clinical trial[J]. Injury, 2023, 54(2):728-737. DOI: 10.1016/j.injury.2022.11.036.
[33] Su K, Bai Y, Wang J, et al. Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous PRP injections to treat patients with knee osteoarthritis[J]. Clin Rheumatol, 2018, 37(5):1341-1350. DOI: 10.1007/s10067-018- 3985-6.
[34] Bansal H, Leon J, Pont JL, et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: correct dose critical for long term clinical efficacy[J]. Sci Rep, 2021, 11(1):3971. DOI: 10.1038/s41598-021-83025-2.
[35] 苏睿,董良,潘钊,等.冷冻保存富血小板血浆对创伤修复的影响及体外机制研究[J].安徽医科大学学报,2024,59(7):1143-1150.DOI:10.19405/j.cnki.issn1000-1492.2024. 07.006.

富血小板血浆治疗膝关节炎的研究进展

Research progress on the treatment of knee osteoarthritis with platelet rich plasma

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics